WELL Health Technologies Corp.

As of June 30, 2026, WELL Health Technologies Corp. carries a market capitalization of 654.97M, placing it among publicly traded companies globally. Its enterprise value stands at 1.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

WELL Health Technologies Corp.'s next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, WELL Health Technologies Corp. has 255.95M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, WELL Health Technologies Corp. maintains a current ratio of 0.80, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, WELL Health Technologies Corp. recorded an income tax benefit of -4.31M rather than an expense, typically from losses, carryforwards, or the release of a tax provision.

As of the close on October 22, 2026, WELL Health Technologies Corp.'s stock has declined approximately 10.49% over the past 52 weeks. The 50-day moving average sits at 2.68, while the 200-day moving average is 2.61.

As of June 30, 2026, WELL Health Technologies Corp. holds 80.57M in cash and equivalents against 510.83M in total debt, resulting in a net debt position of 360.86M. Total book value stands at 510.58M, with working capital of -61.40M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.